For citations:
Aparina T.V., Britov A.N., Dilakyan E.A., Metelskaya V.A., Gomazkov O.A. SIGNIFICANCE OF BASELINE ACE ACTIVITY IN PATIENTS WITH METABOLIC SYNDROME WHEN ADMINISTRATION OF ACE INHIBITORS AND IMIDAZOLINE AGONISTS IS CONSIDERED. Russian Journal of Cardiology. 2001;(2):32-37. (In Russ.)
Email this article 